COVID-19 & Testosterone
Acute-illness suppression versus the contested question of lasting effects
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Not an FDA product (acute-illness association; testosterone not approved for COVID)
Reference only. Not medical advice.
What can go wrong
The risk is over-reading the data: measuring testosterone during or just after acute COVID (when any severe illness lowers it) and concluding the virus caused durable hypogonadism, or inferring from the low-T/severity correlation that testosterone would have been protective. Both leaps outrun the evidence. The commercial risk is marketing that collapses acute suppression, confounded association, and unproven lasting effect into a single 'COVID wrecked your T, buy the fix' claim.
This is something to take to a clinician. The Atlas can tell you what is known about covid-19 & testosterone in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Acute, severe illness of almost any kind suppresses testosterone transiently (the so-called functional, non-thyroidal-illness-like response of the gonadal axis), and COVID-19 is no exception: men hospitalized with COVID frequently had low testosterone, and lower levels correlated with worse severity and outcomes in observational data. The genuinely contested question is whether COVID causes a LASTING reduction beyond the acute episode. Some studies report persistently lower testosterone or testicular effects; others find recovery as the illness resolves and cannot separate the virus from the generic effect of being acutely sick. The disciplined reading: acute suppression is well supported; durable, COVID-specific hypogonadism remains uncertain, and association-with-severity does not prove causation.
Acute illness reliably lowers testosterone - the hard, honest question is whether COVID leaves a lasting dent.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
Severe acute illness suppresses the HPG axis through inflammatory cytokines, stress (cortisol), and the general physiology of critical illness - a functional, usually reversible central suppression seen across pneumonia, sepsis, and surgery, not unique to COVID. SARS-CoV-2 also raises a plausible testicular angle because the ACE2 receptor it uses for entry is expressed in testicular tissue, and some autopsy/biopsy reports described testicular changes - but whether this produces clinically meaningful, lasting hypogonadism in living recovered men is unsettled. The widely reported correlation between low testosterone and COVID severity is real in observational data but bidirectionally confounded: severe illness lowers testosterone, AND men with pre-existing low testosterone tend to have more comorbidity, so the arrow of causation cannot be cleanly assigned.
Why the 'COVID lowers your T' claim needs caution
This is a topic where honesty requires restraint. Three claims must be kept separate. (1) COVID acutely lowers testosterone - well supported, but this is the generic acute-illness response, not a COVID signature. (2) Low testosterone correlates with worse COVID outcomes - real in observational data, but confounded: sicker men (older, more comorbid, more obese) both have lower testosterone and do worse, so this is association, not proven causation, and it does NOT mean giving testosterone would have helped. (3) COVID causes durable, lasting hypogonadism - genuinely unsettled; ACE2 expression in testis and some tissue findings make a testicular effect plausible, and a few studies report persistence, but many men recover as the acute illness resolves and studies struggle to separate virus-specific effects from being-acutely-sick. The supplement and TRT marketing temptation is to collapse all three into 'COVID wrecked your testosterone, here is the fix.' Ēnel will not - the defensible statement is acute suppression yes, lasting COVID-specific hypogonadism unproven.
What people get wrong
Often saidCOVID permanently lowers your testosterone
ActuallyAcute suppression during illness is well supported - but that is the generic response to being severely ill, not a COVID-specific signature. Whether COVID causes a LASTING reduction is genuinely unsettled, with mixed evidence confounded by the acute-illness effect.
Often saidLow T causes severe COVID, so testosterone would protect you
ActuallyThe low-T/severity correlation is observational and confounded - sicker, older, more comorbid men have both lower testosterone and worse outcomes. Association is not causation, and it does not show that giving testosterone would help.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
What we do not know
- Does COVID cause durable, virus-specific hypogonadism, or does testosterone recover as the acute illness resolves?
- Is the testosterone-severity association causal in either direction, or fully explained by shared comorbidity?
At a glance
- Acute effect
- Transient testosterone suppression - well supported, not COVID-specific
- Severity correlation
- Lower T associated with worse COVID outcomes (observational)
- Lasting effect
- Contested - mixed evidence, confounded by acute-illness effect
- Causation
- Severity-association does NOT establish causation
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about COVID-19 & Testosterone. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Hospitalized-COVID testosterone cohorts2020-2021
Men hospitalized with COVID frequently had low testosterone; lower levels correlated with greater severity and mortality (observational, confounded)
ACE2 testicular expression / tissue reports2020-2021
Noted ACE2 expression in testis and some testicular pathological findings, raising a plausible but unproven direct-effect hypothesis
Recovery/longitudinal studies2021-2023
Mixed results on whether testosterone normalizes after recovery; difficulty separating COVID-specific from generic acute-illness effects